Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dixie Brands was a leading consumer packaged goods company in the cannabis industry, specializing in the development and manufacturing of THC and CBD-infused products. The company operated a diverse portfolio of brands, including its flagship Dixie Elixirs, Aceso Wellness for human supplements, and Therabis for pet wellness. Dixie focused on precision dosing and high-quality extraction technologies to deliver consistent therapeutic effects across various delivery formats such as beverages, edibles, and topicals. In 2020, the company merged with BR Brands to form BellRock Brands, creating one of the largest multi-state cannabis platforms in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dixie.